can glp 1 cause hyperthyroidism Implications of GLP-1 Receptor Agonist on Thyroid Function: A Literature Review of Its Effects on Thyroid Volume, Risk of Cancer, Functionality and TSH Levels Why GLP-1 Agonists Are Risky

In the STEP clinical trials, participants who combined semaglutide with lifestyle interventions lost up to 17.4 percent of baseline body weight, compared to 14.9 percent for those with less intensive behavioral support

2001;280:E2709

This information can support a more informed discussion between patient and provider about whether to pursue Weightwatchers-style behavioral programs, compounded GLP-1 medications, or both

In the same study, tissue growth in the areas treated with surgery was reported in approximately 30% of patients [55]

doi: 10.1016/j.ejphar.2020.173102 216 KandaRHiraikeHWada-HiraikeOIchinoseTNagasakaKSasajimaYet al